Compare BRCC & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRCC | INO |
|---|---|---|
| Founded | 2014 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.1M | 133.4M |
| IPO Year | 2022 | 1999 |
| Metric | BRCC | INO |
|---|---|---|
| Price | $8.98 | $1.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.25 | ★ $6.75 |
| AVG Volume (30 Days) | 417.3K | ★ 3.7M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $398,263,000.00 | $42,220,086.00 |
| Revenue This Year | $9.68 | $20,156.19 |
| Revenue Next Year | $9.59 | $421.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.73 | ★ 19.37 |
| 52 Week Low | $0.60 | $0.56 |
| 52 Week High | $10.65 | $2.72 |
| Indicator | BRCC | INO |
|---|---|---|
| Relative Strength Index (RSI) | 78.46 | 53.90 |
| Support Level | $0.92 | $1.22 |
| Resistance Level | $10.65 | $1.79 |
| Average True Range (ATR) | 0.51 | 0.09 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 82.11 | 15.22 |
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.